Multimodality Imaging of Right-Sided (Tricuspid Valve) Papillary Fibroelastoma: Recognition of a Surgically Remediable Disease
Presentation of an increasingly recognized right-sided primary valve tumor of clinical importance: the tricuspid valve papillary fibroelastoma (PF).
Tricuspid valve Endocarditis Following Central Venous Cannulation: The Increasing Problem of Catheter Related Infection
We report a case of tricuspid valve endocarditis, probably secondary to injury of the anterior tricuspid leaflet by the guide wire or the CVC that required open heart surgery with vegetectomy and repair of the tricuspid valve.
Cardioplegia Solution: Buckberg vs Del Nido (EP Video)
Matt Norman discusses the current trends in single dose crystalloid cardioplegia (40:30 minutes).
Cardioplegia Solution: Buckberg vs Del Nido (EP Video)
Matt Norman discusses the current trends in single dose crystalloid cardioplegia (40:30 minutes).
Impact of Smoking Status on Outcomes after Concomitant Aortic Valve Replacement and Coronary Artery Bypass Graft Surgery
There is a paucity of data on the impact of smoking status on outcomes after concomitant aortic valve replacement and coronary artery bypass graft (AVR-CABG) surgery.
Surgery in 2013 and Beyond
This paper will looks at issues and how their impact onThoracic Surgical practice in 2013 and beyond.
Antithrombotic Strategies in Children Receiving Long-Term Berlin Heart EXCOR Ventricular Assist Device Therapy
The use of bivalirudin and epoprostenol infusions as an alternate anti-thrombotic (AT) regimen in pediatric VAD patients was reviewed.
New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists
New oral anticoagulants (OACs) that directly inhibit Factor Xa (FXa) or thrombin have been developed for the long-term prevention of thromboembolic disorders.
The Clinical Utility of Bivalirudin in Patients with cCoronary Artery Disease
We present the major studies that have brought bivalirudin to the forefront of coronary artery disease, specifically coronary interventional procedures.
How to Reduce Mortality in ST-Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Interventions: Cut the Bleeding
The primary purpose of this analysis is to evaluate the hypothesis that the reduction of in-hospital bleeding is the most plausible explanation for the improved survival of STEMI patients treated with bivalirudin during primary PCI.
FDA Regulation of Cardiovascular Devices and Opportunities for Improvement
This article reviews FDA regulation of cardiovascular devices and offers suggestions for strengthening the process while focusing on examples relevant to cardiac electrophysiologists.
Diversity & Disparity Among U.S. Perfusionists (EP Video)
Brian Forsberg presents a case report on diversity and disparity among perfusionists (18:57 minutes).